If you’ve ever met Steve, you know he’s one of the nicest people you’ll ever meet. I’ve worked alongside him for nearly a decade… and I can count on both hands the times I’ve seen him really get upset. But there’s one situation in our business that’s frustrated Steve more than any other I’ve seen.
| This advertisement is from DailyWealth, a free e-letter.
You can unsubscribe here but you will no longer receive DailyWealth. |
| | |
Dear Reader, If you've ever met Steve, you know he's one of the nicest people you'll ever meet. I've worked alongside him for nearly a decade… and I can count on both hands the times I've seen him really get upset. But there's one situation in our business that's frustrated Steve more than any other I've seen. It's impacting investors across the country – and our subscribers. We've been frustrated about this for years. Yet it's still one of the biggest issues in our industry today. Steve recently wrote: "I get so mad, I just want to scream. Brokerage firms are reluctant to sell investments they don't make much money on… even if it means LYING to your face." And now it's directly affecting some of our readers. Our Director of Member Services, Mike Cottet, has just released an urgent message, explaining the situation and the action we're taking to fight back. Please, take a few minutes to listen to what Mike has to say. We believe it could seriously affect your wealth over the next few years. Click here for the full story. Sincerely,
Brett Eversole
Senior Analyst, True Wealth |
|
|
All contents of this e-mail are copyright 2018 by Stansberry Research. All rights reserved. Reproducing any part of this document is prohibited without the express written consent of Porter Stansberry. Protected by U.S. Copyright Law {Title 17 U.S.C. Section 101 et seq., Title 18 U.S.C. Section 2319}: Infringements can be punishable by up to five years in prison and $250,000 in fines.
DISCLAIMER: The work included in this publication is based on SEC filings, current events, interviews, and corporate press releases. It may contain errors, and you shouldn't make any investment decision based solely on what you read here. It's your money and your responsibility. The views expressed in this publication do not necessarily reflect the views of Stansberry Research.
You're receiving this email at [email protected]. If you have any questions about your subscription, or would like to change your email settings, please contact Stansberry Research at (888) 261-2693 Monday-Friday between 9:00 a.m. and 5:00 p.m. Eastern Time. Or if calling internationally, please call 443-839-0986. Stansberry Research, 1125 N Charles Street Baltimore, MD 21201. If you wish to contact us by email, please do not reply to this message but instead go to [email protected].
To unsubscribe from this mailing, click here: Unsubscribe
|
|
|
